TAMBE Japan Post-Marketing Surveillance
NCT: NCT07147569 · RECRUITING
NCT IDNCT07147569
StatusRECRUITING
Start Date2026-03-27
Completion2034-02-28
Brief Summary
To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.
Frequently Asked Questions
What is TAMBE Japan Post-Marketing Surveillance?
TAMBE Japan Post-Marketing Surveillance is a clinical trial registered under NCT07147569. Current status: RECRUITING.
What is the status of NCT07147569?
The current status of NCT07147569 (TAMBE Japan Post-Marketing Surveillance) is: RECRUITING.
When did TAMBE Japan Post-Marketing Surveillance start?
TAMBE Japan Post-Marketing Surveillance started on 2026-03-27.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.